Difficulty: Medium
Average Score: 93%
Practice
Gentamicin may produce which of the following adverse effect:
Correct answer
D
Rationale
In the context of chemotherapy drugs, Gentamicin is known to produce significant nephrotoxicity as an adverse effect. Nephrotoxicity refers to damage to the kidneys, which can manifest as impaired kidney function and potentially lead to acute kidney injury. Gentamicin is an aminoglycoside antibiotic commonly used to treat various bacterial infections.
Option A, significant hepatotoxicity, is incorrect because Gentamicin primarily affects the kidneys, not the liver. Option B, significant cardiotoxicity, is also incorrect as Gentamicin is not known to cause adverse effects on the heart. Option C, significant dermal toxicity, is not associated with Gentamicin use; dermal toxicity typically refers to skin reactions which are not a common side effect of this drug.
Understanding the adverse effects of chemotherapy drugs is crucial for healthcare providers to monitor patients for potential complications and provide appropriate care. By knowing that Gentamicin can lead to nephrotoxicity, healthcare professionals can take proactive measures to prevent or manage kidney-related issues in patients receiving this medication. This knowledge enhances patient safety and contributes to improved treatment outcomes.
Option A, significant hepatotoxicity, is incorrect because Gentamicin primarily affects the kidneys, not the liver. Option B, significant cardiotoxicity, is also incorrect as Gentamicin is not known to cause adverse effects on the heart. Option C, significant dermal toxicity, is not associated with Gentamicin use; dermal toxicity typically refers to skin reactions which are not a common side effect of this drug.
Understanding the adverse effects of chemotherapy drugs is crucial for healthcare providers to monitor patients for potential complications and provide appropriate care. By knowing that Gentamicin can lead to nephrotoxicity, healthcare professionals can take proactive measures to prevent or manage kidney-related issues in patients receiving this medication. This knowledge enhances patient safety and contributes to improved treatment outcomes.